After Hours Summary: WMGI +5%, DEPO +5%, RRGB +3%, FSLR +2% following earnings/guidance, NVDQ +25% continued strength following Cigna coverage news... SREV -25%, TXRH -10%, WLL -4.2% following earnings/guidanceAfter Hours Gainers:
Companies trading higher in after hours in reaction to earnings/guidance: LNTH +7% (also the company and GE Healthcare sign a a term sheet relating to the continued Phase III development and worldwide commercialization of flurpiridaz F18), WMGI +5.4%, DEPO +4.6%, DL +4.3%, XPO +3.7%, SRT +3.4%, RRGB +3.3%, HCLP +3.2% (light volume), VMI +2.2%, EXR +2% (ticking higher), FSLR +1.8% (also secures syndicated financing arranged by Mizuho Bank for utility-scale solar project in Japan), UVE +1.7%, LZB +1.4%, WCN +1.1%
Companies trading higher in after hours in reaction to news: NVDQ +25.3% (continued strength after confirming Cigna now covers Dermacell for breast reconstruction surgery and Dermacell AWM for diabetic foot ulcers), TRCO +3% (Starboard Value discloses 6.6% active stake)
After Hours Losers:
Companies trading lower in after hours in reaction to earnings/guidance: SREV -24.8%, TXRH -10.1%, FUEL -9.8%, DAC -7.4% (ticking lower), WLL -4.2%, PZZA -3.5%, FE -2.9%, KAR -2.5%, NEM -2.1% (also reports gold reserves of 68.5 mln oz for 2016 vs 71.1 mln oz in 2015; provides FY17 capex guidance), SAND -1.7% (light volume), NFX -1.2%
Companies trading lower in after hours in reaction to news: PKD -10.6% (commences 12 mln common stock offering and $50 mln public offering of Series A Mandatory Convertible Preferred Stock), GBT -10% (to sell $75 mln in shares of its common stock in a registered underwritten public offering), AGEN -6.2% (discloses that the Alliance for Clinical Trials in Oncology's Data and Safety Monitoring Board interim analysis for futility of the Phase II trial of Prophage G-200 vaccine in combination with bevacizumab suggested that the trial is unlikely to demonstrate that the vaccine will lead to a better survival than bevacizumab as a monotherapy), TLLP -2.5% (commences 5 mln common units offering), YUM -2% (following block trade pricing), CUZ -1.5% (commences public offering of 63,571,336 shares of its common stock - includes 25 mln shares offered by the company)